Background: Metabolic disturbance commonly occurs during pregnancy and perinatal outcome harms, with increased maternal-fetal morbidity. The prevalence of diabetes during pregnancy in Mexico is 7%.
Objective: To develop a guideline available to the staff of the first, second and third level of care, that includes recommendations based on the best available evidence.